Viewing Study NCT04840992


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2025-12-28 @ 5:15 PM
Study NCT ID: NCT04840992
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2021-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Sponsor: CanSino Biologics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module